Vaccination drastically reduces avian influenza outbreaks in ducks, but enhanced passive surveillance is crucial for timely and effective detection of the virus.
Arrowhead spotlights key pancreatitis figures from Phase 3 lipid disease study to differentiate itself from Ionis
Arrowhead Pharmaceuticals has unveiled highly anticipated pancreatitis results from a late-phase trial of plozasiran for a rare lipid disorder, several months after reporting topline data
September 3, 2024